Close

Rating History for Magenta Therapeutics (MGTA) by Mizuho

More Stocks Rated by Mizuho | Latest Ratings for MGTA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/18/2022 Vamil Divan Maintain Buy
(N/A)		 8.00
(17.00)		  
 		   Details